Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clotrimazole lozenge for oropharyngeal candidiasis (phase 3, randomized double-blind active-control)
ChiCTR2200062430Phase 3Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clotrimazole in oral candidiasis (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Total clinical resolution and Safety. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
clotrimazole
03
Conditions
oral candidiasis
Beyond the preview
Go deeper on ChiCTR2200062430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062430.